MicroRNA-323a-3p Negatively Regulates NEK6 in Colon Adenocarcinoma Cells

Zhongshi Hong1, Zhichuan Chen1, Jianpeng Pan1

  • 1Department of General Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian, China.

Journal of Oncology
|January 31, 2022
PubMed
Abstract

Insights

MicroRNA miR-323a-3p targets NEK6 in colon adenocarcinoma (COAD) cells, inhibiting cancer cell proliferation, migration, and invasion. This finding offers new insights into COAD development and potential therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Nekrotizing kinase 6 (NEK6) activity is elevated in colon adenocarcinoma (COAD), a common cancer.
  • The regulatory role of microRNAs (miRNAs) on NEK6 in COAD remains largely unexplored.

Purpose of the Study:

  • To investigate the impact of microRNAs targeting NEK6 in COAD cells.
  • To elucidate the specific role of miR-323a-3p in regulating NEK6 expression and function in COAD.

Main Methods:

  • Bioinformatic analysis of public datasets for NEK6 and miR-323a-3p expression and patient survival.
  • Quantitative real-time PCR and Western blotting to assess NEK6 and miR-323a-3p levels in COAD cells.
  • Dual-luciferase reporter assays to confirm direct targeting of NEK6 by miR-323a-3p.
  • Cell-based assays (MTT, EdU, PI staining, Annexin V/PI, Transwell) to evaluate proliferation, apoptosis, migration, and invasion.

Main Results:

  • NEK6 was highly expressed, while miR-323a-3p was lowly expressed in COAD cells, with a negative correlation observed.
  • Upregulation of miR-323a-3p suppressed COAD cell proliferation, migration, and invasion, while promoting apoptosis.
  • Overexpression of NEK6 counteracted the inhibitory effects of miR-323a-3p on cell growth and apoptosis.

Conclusions:

  • miR-323a-3p directly targets and downregulates NEK6 expression in COAD cells.
  • The miR-323a-3p/NEK6 axis plays a critical role in regulating COAD cell behavior.
  • This study provides a novel molecular mechanism contributing to COAD pathogenesis and suggests potential therapeutic targets.